Sunil Healthcare Ltd

AGM details

• AGM held on 28 September 2026 via video conferencing at 12:30 PM.
• Meeting started 12:30 PM and concluded 12:46 PM.
• Remote e-voting 25–27 September 2026; Insta Poll for 30 minutes post-AGM.

Resolutions and voting

• Adoption of audited financial statements for year ended 31 March 2026; ordinary resolution passed.
• Re-appointment of Sanjay Kumar Kaushik as Non-Executive Director; ordinary resolution passed.

Director changes

• Sanjay Kumar Kaushik re-appointed as Non-Executive Director (retiring by rotation).

AGM Details

• Date and time: 28 September 2026, 12:30 PM IST; VC/OAVM.
• Venue deemed at registered office; meeting ended 12:46 PM.
• Insta vote available for 30 minutes after AGM.

Key Resolutions

• Resolution 1 (Ordinary): Adopt audited standalone and consolidated financial statements for FY 2025-26.
• Resolution 2 (Ordinary): Re-appoint Sanjay Kumar Kaushik as Non-Executive Director.

Voting Results

• Outcome of voting is to be announced separately; Scrutinizer's report forthcoming.

Sunil Healthcare Ltd trading window closure from October 01, 2026 till 48 hours after the declaration of Un-Audited Financial results for the 2nd quarter/half year of Financial year 2026-27 ended on September 30, 2026

Book Closure & AGM Details

• Book closure: 22.09.2026 to 28.09.2026 inclusive for the 52nd AGM.
• Purpose: to enable the 52nd AGM; venue deemed at registered office.
• AGM date/time: 28 September 2026 at 12:30 IST, via VC/OAVM.
• Cut-off date for voting: 21 September 2026; entitles electronic voting.
• Remote e-voting window: 25 Sep 2026 09:00 to 27 Sep 2026 17:00.
• Agency: MUFG Intime India Private Limited to conduct e-voting and VC.
• Security: equity shares, voting eligibility for holders whether in physical or dematerialized form.

Financial highlights

• Standalone revenue from operations: ₹8,771.92 L, up 5.15% YoY.
• Standalone EBITDA: ₹1,510.31 L (before exceptional items).
• Standalone PAT: ₹-530.21 L; EPS: ₹-5.17.
• Consolidated revenue: ₹8,771.92 L; Consolidated PAT: ₹400.60 L; EPS: ₹3.91.
• Consolidated EBITDA: ₹1,494.46 L.
• Dividend not declared for FY2025-26.

Operations & capacity

• Installed capsule-shell capacity raised to 15 billion per annum.
• Nine capsule sizes offered: 00, 0SEL, 0EL, 0, 1, 2, 3, 4, 5.
• Plant located in Alwar, Rajasthan; registered office in New Delhi.
• WHO-GMP certified; Star Export House; strong export presence.
• HPMC capsule production started in August 2018.

Capital structure & dividends

• Equity share capital ₹1,025.48 L; authorised capital ₹17 Cr; Redeemable Pref ₹6.20 Cr.
• Dividend policy: no dividend; no buybacks; no differential rights issues.
• Unpaid/Unclaimed dividend transferred to IEPF; company has not paid dividends since 2008-09.

Debt & liquidity

• Total borrowings: ₹5,578.48 L; non-current ₹1,550.59 L; current ₹4,027.89 L.
• Redeemable Preference shares: ₹177.15 L.
• Liquidity: cash ₹7.39 L; bank balances ₹225.48 L; total liquid funds ₹232.87 L.
• Credit rating: CARE BB+ (Stable); CARE A4+; downgrade from prior ratings.

Governance & risk

• Board comprises 8 directors; 5 Independent Directors; independence confirmed.
• Audit Committee met 4 times; all recommendations were accepted.
• Secretarial Audit: no qualifications; internal auditors appointed.
• Whistle Blower policy in place; no complaints in year.
• Management reports robust internal controls; SAP IT system in use.

Material events & subsidiaries

• Exceptional items: impairment of subsidiary receivables ₹946.66 L; PPE write-off ₹355.95 L; insurance receivable ₹344.36 L.
• Fire incident at Alwar plant; PPE damaged; insured; recovery expected.
• Subsidiaries: Sunil Healthcare North America LLC (100%); Sunil Healthcare Mexico SA DE CV (99.97%).
• FX exposure managed under policy; currency risk monitored and mitigated.

Outlook & risks

• Indian pharma market growth is favorable; GDP growth around 7.5% in FY26.
• FX volatility, geopolitical risks, and import dependencies pose risks.
• Strategic focus on cost optimization and expanding exports to sustain growth.

AGM details

• 52nd AGM on 28 September 2026 at 12:30 IST via VC/OAVM.
• Venue deemed at the registered office for VC/OAVM.
• Remote e-voting window: 9:00 AM Sep 25 to 5:00 PM Sep 27, 2026.
• Register of Members close 22–28 September 2026 (inclusive).
• Proxy attendance facility dispensed; proxies not allowed for this AGM.
• Members may join 30 minutes before the start of the meeting.

Resolutions

• Ordinary resolution: adopt audited annual financial statements for year ended 31 March 2026.
• Ordinary resolution: re-appoint Mr. Sanjay Kumar Kaushik as Non-Executive Director (retire by rotation).

Director appointment details

• Sanjay Kumar Kaushik re-appointed; remuneration limited to sitting fees.
• Last remuneration drawn FY 2025-26: Rs 93,500.
• Committee memberships: Audit; Stakeholders Relationship; Nomination and Remuneration.

Other governance notes

• Scrutinizer appointed: ATCS & Associates, practicing company secretaries.
• e-voting providers: MUFG Intime (Instavote) and InstaMeet for attendance.
• Vote cut-off date for remote e-voting: 21 September 2026.

Financial results

• Unaudited standalone and consolidated results approved for quarter ended June 30, 2026.

e-voting and scrutiny providers

• MUFG InTime India Pvt. Ltd appointed for remote e-voting and VC for 52nd AGM on Sep 28, 2026.
• ATCS & Associates appointed as Scrutinizer for AGM e-voting.

AGM timing and book closure

• Book closure from 22.09.2026 to 28.09.2026 for AGM.
• Ensuing AGM fixed for Sep 21, 2026 via VC/AVM; cut-off date set for Sep 21, 2026.

Tax matters

• Exercising Section 200 IT Act option for deferred tax on gain from fair valuation; net changes recognized.

Auditor reviews

• Independent auditor's review reports on standalone and consolidated results; no material misstatement identified.